Prognostic factors and clinical features in patients with leptominengeal metastases from breast cancer: A single center experience

Icro Meattini, Lorenzo Livi, Calogero Saieva, Davide Franceschini, Livia Marrazzo, Daniela Greto, Vieri Scotti, Silvia Scoccianti, Fabiola Paiar, Lorenzo Bordi, Jacopo Nori, Luis Sanchez, Lorenzo Orzalesi, Simonetta Bianchi, Giampaolo Biti

Research output: Contribution to journalArticlepeer-review

Abstract

Background: Meningeal carcinomatosis (MC) is a rare complication in breast cancer (BC) with no efficient modality of treatment yet found; overall survival (OS) generally did not exceed six months. We reviewed the experience of the University of Florence focusing on prognostic factors and MC survival. Patients and methods: We analyzed 33 patients treated for MC from BC between 2002 and 2010. Results: Mean OS from MC diagnosis was 4.9 months. At survival analysis clinical stage emerged as the only statistical significant parameter (P=0.009) among BC diagnosis features. Among MC diagnosis parameters, more than three metastases at diagnosis (P=0.037), multimodality treatment (P=0.014) and poor performance status (P=0.003) reached the statistical significance. At multivariate analysis only performance status at MC diagnosis maintained the statistical significance (P=0.0047; HR: 3.34; CI 95% 1.45-7.73). Conclusions: Our experience confirms that performance status is probably the most important prognostic factor in these patients. Multimodality approach is probably the best option.

Original languageEnglish
Pages (from-to)279-284
Number of pages6
JournalJournal of Chemotherapy
Volume24
Issue number5
DOIs
Publication statusPublished - Oct 2012

Keywords

  • Breast cancer
  • Leptomeningeal metastases
  • Meningeal carcinomatosis
  • Performance status
  • Prognostic factors

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Infectious Diseases
  • Oncology
  • Pharmacology

Fingerprint Dive into the research topics of 'Prognostic factors and clinical features in patients with leptominengeal metastases from breast cancer: A single center experience'. Together they form a unique fingerprint.

Cite this